TGFβ signaling through Smad activation is regarded as tumor suppressive during the early stages of cancer and pre-cancerous lesions as it has been shown that loss of TGFβ tumor suppressor signaling has been associated with tumor initiation and progression of several types of tumors including colon cancer. Here, TGFB1 is linked to neoplasm.